Maktuda
(1R,2S,6R,7S)-4-[[(1R,2R)-2-[[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 213046.
Registration
- Applicants
- 1
- Registrations
- 5
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Maktuda 20 MG EACH TABLET CONTAINS LURASIDONE HYDROCHLORIDE 20,0 mg | 20 mgFilm coated tablet | 570772.76757/1.2/0772.767Approved 27 August 2024 | Registered | Not determined | PIPIL |
| Maktuda 40 MG EACH TABLET CONTAINS LURASIDONE HYDROCHLORIDE 40,0 mg | 40 mgFilm coated tablet | 570773.76857/1.2/0773.768Approved 27 August 2024 | Registered | Not determined | PIPIL |
| Maktuda 60 MG EACH TABLET CONTAINS LURASIDONE HYDROCHLORIDE 60,0 mg | 60 mgFilm coated tablet | 570774.76957/1.2/0774.769Approved 27 August 2024 | Registered | Not determined | PIPIL |
| Maktuda 80 MG EACH TABLET CONTAINS LURASIDONE HYDROCHLORIDE 80,0 mg | 80 mgFilm coated tablet | 570775.77057/1.2/0775/770Approved 27 August 2024 | Registered | Not determined | PIPIL |
| Maktuda 120 MG EACH TABLET CONTAINS LURASIDONE HYDROCHLORIDE 120,0 mg | 120 mgFilm coated tablet | 570776.77157/1.2/0776.771Approved 27 August 2024 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Lurasidone
Consolidated Schedules 06 July 2026, line 6978
5 of 5 approved products with this ingredient carry S5 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.